United States Patent and Trademark Office
Alnylam Receives Notice of Allowance from United States Patent and Trademark Office (USPTO) for New Patent Broadly ...Alnylam Pharmaceuticals, Inc. , a leading RNAi therapeutics company, announced today that the United States Patent and Trademark Office has issued a Notice of Allowance for patent application number 12/813,448, covering the company’s proprietary second generation lipid nanoparticle platform, including the “MC3” lipid.Business Wire via Yahoo! Finance - Jan 30 05:00am
U.S. Patent and Trademark Office Selects Unisys for Software Development for Next-Generation SystemsBLUE BELL, Pa., Feb. 7, 2012 /PRNewswire/ -- The United States Patent and Trademark Office (USPTO), part of the U.S. Department of Commerce, has awarded Unisys (NYSE: UIS - News) a contract to compete for task ...PR Newswire via Yahoo! Finance - Feb 07 05:00am
Cumberland Receives Acetadote® Patent Notice of AllowanceNASHVILLE, Tenn., Feb. 8, 2012 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX - News) today announced that it has received a Notice of Allowance from the United States Patent and Trademark Office ...PR Newswire via Yahoo! Finance - Feb 08 01:20pm
Tekmira Announces USPTO Issuance of Key Patents Broadly Covering LNP Formulations and Mitigation of Immune StimulationVANCOUVER, B.C. -- Tekmira Pharmaceuticals Corporation , a leading developer of RNA interference (RNAi) therapeutics, announced today that the United States Patent & Trademark Office (USPTO) has recently ...GlobeNewswire via Yahoo! Finance - Feb 09 05:00am